GB242

AssetAlso folic acid, NSC-3073, Bio science, Folacin

Involved in one-carbon metabolism and nucleotide synthesis, co-administered in antifolate therapy

Stage: Phase 3
Modality: Small molecule
Target: Inflammation; 1
Indication: 166
Trials: 1
Developer

Indications

1

Rheumatoid arthritis
Phase 3, Unknown, NCT04178850, clinicaltrials.gov, 7 Oct 2026

In the full profile

Targets and what it contains2
Owner and partners1
Trials166
Evidence for its targets2
Competitors12
Aging relevance2
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.